Phase III Trial of CCNU/Temozolomide (TMZ) Combination Therapy vs. Standard TMZ Therapy for Newly Diagnosed MGMT-methylated Glioblastoma Patients
Phase of Trial: Phase III
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Lomustine (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Acronyms CeTeG
- 31 May 2017 Status changed from active, no longer recruiting to completed.
- 03 Jun 2015 Planned End Date changed from 1 Feb 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
- 03 Jun 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Nov 2015 as per ClinicalTrials.gov record.